{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:14:29Z","timestamp":1789024469641,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Trematode infections such as schistosomiasis and fascioliasis cause significant morbidity in an estimated 250 million people worldwide and the associated agricultural losses are estimated at more than US$ 6 billion per year. Current chemotherapy is limited. Triosephosphate isomerase (TIM), an enzyme of the glycolytic pathway, has emerged as a useful drug target in many parasites, including<jats:italic>Fasciola hepatica<\/jats:italic>TIM (<jats:italic>Fh<\/jats:italic>TIM). We identified 21 novel compounds that selectively inhibit this enzyme. Using microscale thermophoresis we explored the interaction between target and compounds and identified a potent interaction between the sulfonyl-1,2,4-thiadiazole (compound<jats:bold>187<\/jats:bold>) and<jats:italic>Fh<\/jats:italic>TIM, which showed an IC<jats:sub>50<\/jats:sub>of 5\u2009\u00b5M and a K<jats:sub>d<\/jats:sub>of 66\u2009nM. In only 4\u2009hours, this compound killed the juvenile form of<jats:italic>F. hepatica<\/jats:italic>with an IC<jats:sub>50<\/jats:sub>of 3\u2009\u00b5M, better than the reference drug triclabendazole (TCZ). Interestingly, we discovered<jats:italic>in vitro<\/jats:italic>inhibition of<jats:italic>Fh<\/jats:italic>TIM by TCZ, with an IC<jats:sub>50<\/jats:sub>of 7\u2009\u00b5M suggesting a previously uncharacterized role of<jats:italic>Fh<\/jats:italic>TIM in the mechanism of action of this drug. Compound<jats:bold>187<\/jats:bold>was also active against various developmental stages of<jats:italic>Schistosoma mansoni<\/jats:italic>. The low toxicity<jats:italic>in vitro<\/jats:italic>in different cell types and lack of acute toxicity in mice was demonstrated for this compound, as was demonstrated the efficacy of<jats:bold>187<\/jats:bold><jats:italic>in vivo<\/jats:italic>in<jats:italic>F. hepatica<\/jats:italic>infected mice. Finally, we obtained the first crystal structure of<jats:italic>Fh<\/jats:italic>TIM at 1.9\u2009\u00c5 resolution which allows us using docking to suggest a mechanism of interaction between compound<jats:bold>187<\/jats:bold>and TIM. In conclusion, we describe a promising drug candidate to control neglected trematode infections in human and animal health.<\/jats:p>","DOI":"10.1038\/s41598-020-59460-y","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T11:03:11Z","timestamp":1581591791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0865-8507","authenticated-orcid":false,"given":"Florencia","family":"Ferraro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Corvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Bergalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ilarraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Susuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor R.","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Timson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6378-3303","authenticated-orcid":false,"given":"Christophe","family":"Guillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-6100","authenticated-orcid":false,"given":"Guzm\u00e1n","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"59460_CR1","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nchembio837","volume":"2","author":"AR Renslo","year":"2006","unstructured":"Renslo, A. R. & McKerrow, J. H. Drug discovery and development for neglected parasitic diseases. Nat. Chem. Biol. 2, 701\u2013710 (2006).","journal-title":"Nat. Chem. Biol."},{"key":"59460_CR2","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1098\/rstb.2009.0089","volume":"364","author":"MW Robinson","year":"2009","unstructured":"Robinson, M. W. & Dalton, J. P. Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases. Philos. Trans. R. Soc. B Biol. Sci. 364, 2763\u20132776 (2009).","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"59460_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/0014-4894(81)90036-9","volume":"51","author":"AGM Tielens","year":"1981","unstructured":"Tielens, A. G. M., Van Der Meer, P. & Van Den Bergh, S. G. Fasciola hepatica: Simple, large-scale, in vitro excystment of metacercariae and subsequent isolation of juvenile liver flukes. Exp. Parasitol. 51, 8\u201312 (1981).","journal-title":"Exp. Parasitol."},{"key":"59460_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.pt.2016.03.002","volume":"32","author":"JM Kelley","year":"2016","unstructured":"Kelley, J. M. et al. Current Threat of Triclabendazole Resistance in Fasciola hepatica. Trends Parasitol. 32, 458\u2013469 (2016).","journal-title":"Trends Parasitol."},{"key":"59460_CR5","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1371\/journal.pntd.0000478","volume":"3","author":"MH Abdulla","year":"2009","unstructured":"Abdulla, M. H. et al. Drug discovery for schistosomiasis: Hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl. Trop. Dis. 3, e478 (2009).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"59460_CR6","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.1128\/AAC.00828-10","volume":"54","author":"U Duthaler","year":"2010","unstructured":"Duthaler, U., Smith, T. A. & Keiser, J. In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78. Antimicrob. Agents Chemother. 54, 4596\u20134604 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"59460_CR7","doi-asserted-by":"crossref","unstructured":"Pinto-almeida, A., Mendes, T., Ferreira, P., Belo, S. & De, F. Comparative Proteomics Reveals Characteristic Proteins on Praziquantel-resistance in Schistosoma mansoni. bioRxiv (2018).","DOI":"10.1101\/314724"},{"key":"59460_CR8","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/j.biochi.2013.08.014","volume":"95","author":"VL Zinsser","year":"2013","unstructured":"Zinsser, V. L., Hoey, E. M., Trudgett, A. & Timson, D. J. Biochemical characterisation of triose phosphate isomerase from the liver fluke Fasciola hepatica. Biochim. 95, 2182\u20139 (2013).","journal-title":"Biochim."},{"key":"59460_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.bbapap.2014.02.008","volume":"1844","author":"VL Zinsser","year":"2014","unstructured":"Zinsser, V. L., Hoey, E. M., Trudgett, A. & Timson, D. J. Biochemical characterisation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) from the liver fluke, Fasciola hepatica. Biochim. Biophys. Acta - Proteins Proteom. 1844, 744\u2013749 (2014).","journal-title":"Biochim. Biophys. Acta - Proteins Proteom."},{"key":"59460_CR10","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1021\/jm050237b","volume":"49","author":"C Dax","year":"2006","unstructured":"Dax, C. et al. Selective irreversible inhibition of fructose 1,6-bisphosphate aldolase from Trypanosoma brucei. J. Med. Chem. 49, 1499\u20131502 (2006).","journal-title":"J. Med. Chem."},{"key":"59460_CR11","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/pro.5560030510","volume":"3","author":"SC Mande","year":"1994","unstructured":"Mande, S. C. et al. Crystal structure of recombinant human triosephosphate isomerase at 2.8 A resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme. Protein Sci. 3, 810\u2013821 (1994).","journal-title":"Protein Sci."},{"key":"59460_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/1389203719666181026170751","volume":"20","author":"M Rodr\u00edguez-bola\u00f1os","year":"2019","unstructured":"Rodr\u00edguez-bola\u00f1os, M. & Perez-montfort, R. Medical and Veterinary Importance of the Moonlighting Functions of Triosephosphate Isomerase. Curr. Protein Pept. Sci. 20, 304\u2013315 (2019).","journal-title":"Curr. Protein Pept. Sci."},{"key":"59460_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0022-2836(02)00809-4","volume":"322","author":"A Rodriguez-Romero","year":"2002","unstructured":"Rodriguez-Romero, A. et al. Structure and inactivation of triosephosphate isomerase from Entamoeba histolytica. J. Mol. Biol. 322, 669\u2013675 (2002).","journal-title":"J. Mol. Biol."},{"key":"59460_CR14","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.jmb.2004.06.056","volume":"341","author":"A T\u00e9llez-Valencia","year":"2004","unstructured":"T\u00e9llez-Valencia, A. et al. Inactivation of Triosephosphate Isomerase from Trypanosoma cruzi by an Agent that Perturbs its Dimer Interface. J. Mol. Biol. 341, 1355\u20131365 (2004).","journal-title":"J. Mol. Biol."},{"key":"59460_CR15","doi-asserted-by":"publisher","first-page":"25106","DOI":"10.1074\/jbc.M202419200","volume":"277","author":"K Maithal","year":"2002","unstructured":"Maithal, K., Ravindra, G., Balaram, H. & Balaram, P. Inhibition of Plasmodium falciparum triose-phosphate isomerase by chemical modification of an interface cysteine: Electrospray ionization mass spectrometric analysis of differential cysteine reactivities. J. Biol. Chem. 277, 25106\u201325114 (2002).","journal-title":"J. Biol. Chem."},{"key":"59460_CR16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0006-291X(02)00796-9","volume":"295","author":"A T\u00e9llez-Valencia","year":"2002","unstructured":"T\u00e9llez-Valencia, A. et al. Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 295, 958\u2013963 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"59460_CR17","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1016\/j.ejmech.2010.09.034","volume":"45","author":"G Alvarez","year":"2010","unstructured":"Alvarez, G. et al. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity. Eur. J. Med. Chem. 45, 5767\u20135772 (2010).","journal-title":"Eur. J. Med. Chem."},{"key":"59460_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/vetsci5030074","volume":"5","author":"L Saramago","year":"2018","unstructured":"Saramago, L. et al. Novel and Selective Rhipicephalus microplus Triosephosphate Isomerase Inhibitors with Acaricidal Activity. Vet. Sci. 5, 74 (2018).","journal-title":"Vet. Sci."},{"key":"59460_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4155\/fmc.09.12","volume":"1","author":"G Zinzalla","year":"2009","unstructured":"Zinzalla, G. & Thurston, D. E. Targeting protein-protein interactions for therapeutic intervention: a challenge for the future. Future Med. Chem. 1, 65\u201393 (2009).","journal-title":"Future Med. Chem."},{"key":"59460_CR20","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/cmdc.201500385","volume":"11","author":"E Aguilera","year":"2016","unstructured":"Aguilera, E. et al. Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity. Chem. Med. Chem 11, 1328\u20131338 (2016).","journal-title":"Chem. Med. Chem"},{"key":"59460_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0305-0491(00)00245-5","volume":"127","author":"D Rakus","year":"2000","unstructured":"Rakus, D., Skalecki, K. & Dzugaj, A. Kinetic properties of pig (Sus scrofa domestica) and bovine (Bos taurus) D-fructose-1,6-bisphosphate 1-phosphohydrolase (F1,6BPase): Liver-like isozymes in mammalian lung tissue. Comp. Biochem. Physiol. - B Biochem. Mol. Biol. 127, 123\u2013134 (2000).","journal-title":"Comp. Biochem. Physiol. - B Biochem. Mol. Biol."},{"key":"59460_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.taap.2008.11.010","volume":"234","author":"L Wei","year":"2009","unstructured":"Wei, L. et al. Metabolic profiling studies on the toxicological effects of realgar in rats by (1)H NMR spectroscopy. Toxicol. Appl. Pharmacol. 234, 314\u201325 (2009).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"59460_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbadis.2014.10.010","volume":"1852","author":"BP Roland","year":"2015","unstructured":"Roland, B. P. et al. Triosephosphate Isomerase I170V Alters Catalytic Site, Enhances Stability and Induces Pathology in a Drosophila Model of TPI Deficiency. Biochim. Biophys. Acta. 1852, 61\u201369 (2015).","journal-title":"Biochim. Biophys. Acta."},{"key":"59460_CR24","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/j.biochi.2012.07.001","volume":"94","author":"S Mukherjee","year":"2012","unstructured":"Mukherjee, S., Roychowdhury, A., Dutta, D. & Das, A. K. Crystal structures of triosephosphate isomerase from methicillin resistant Staphylococcus aureus MRSA252 provide structural insights into novel modes of ligand binding and unique conformations of catalytic loop. Biochim. 94, 2532\u20132544 (2012).","journal-title":"Biochim."},{"key":"59460_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1017\/S003118200100124X","volume":"124","author":"MW Robinson","year":"2002","unstructured":"Robinson, M. W., Trudgett, A., Hoey, E. M. & Fairweather, I. Triclabendazole-resistant Fasciola hepatica: \u03b2-tubulin and response to in vitro treatment with triclabendazole. Parasitology 124, 325\u2013338 (2002).","journal-title":"Parasitology"},{"key":"59460_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.molbiopara.2009.07.002","volume":"168","author":"L Rufener","year":"2009","unstructured":"Rufener, L., Kaminsky, R. & M\u00e4ser, P. In vitro selection of Haemonchus contortus for benzimidazole resistance reveals a mutation at amino acid 198 of \u03b2-tubulin. Mol. Biochem. Parasitol. 168, 120\u2013122 (2009).","journal-title":"Mol. Biochem. Parasitol."},{"key":"59460_CR27","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1039\/C7MD00067G","volume":"8","author":"I Ali","year":"2017","unstructured":"Ali, I., Lone, M. N. & Aboul-Enein, H. Y. Imidazoles as potential anticancer agents. Medchemcomm 8, 1742\u20131773 (2017).","journal-title":"Medchemcomm"},{"key":"59460_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2885.1986.tb00011.x","volume":"9","author":"RH Fetterer","year":"1986","unstructured":"Fetterer, R. H. The effect of albendazole and triclabendazole on colchicine binding in the liver fluke Fasciola hepatica. J. Vet. Pharmacol. Ther. 9, 49\u201354 (1986).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"59460_CR29","doi-asserted-by":"publisher","first-page":"e01","DOI":"10.1371\/journal.pntd.0000001","volume":"1","author":"V Olivares-Illana","year":"2007","unstructured":"Olivares-Illana, V. et al. Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi. PLoS Negl. Trop. Dis. 1, e01\u201308 (2007).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"59460_CR30","doi-asserted-by":"crossref","unstructured":"McArthur, C., Gallazzi, F., Quinn, T. P. & Singh, K. HIV Capsid Inhibitors Beyond PF74. Diseases. 30, pii: E56 (2019).","DOI":"10.3390\/diseases7040056"},{"key":"59460_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jmgm.2015.02.002","volume":"58","author":"L Minini","year":"2015","unstructured":"Minini, L. et al. Molecular docking and molecular dynamics simulation studies of Trypanosoma cruzi triosephosphate isomerase inhibitors. Insights into the inhibition mechanism and selectivity. J. Mol. Graph. Model. 58, 40\u201349 (2015).","journal-title":"J. Mol. Graph. Model."},{"key":"59460_CR32","doi-asserted-by":"publisher","first-page":"e35033","DOI":"10.1371\/journal.pone.0035033","volume":"7","author":"F Ross","year":"2012","unstructured":"Ross, F. et al. Identification of thioredoxin glutathione reductase inhibitors that kill cestode and trematode parasites. PLoS One 7, e35033 (2012).","journal-title":"PLoS One"},{"key":"59460_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bmc.2007.09.016","volume":"16","author":"A Castro","year":"2008","unstructured":"Castro, A. et al. Non-ATP competitive glycogen synthase kinase 3beta (GSK-3beta) inhibitors: study of structural requirements for thiadiazolidinone derivatives. Bioorg. Med. Chem. 16, 495\u2013510 (2008).","journal-title":"Bioorg. Med. Chem."},{"key":"59460_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3109\/14756366.2013.765415","volume":"29","author":"G Alvarez","year":"2014","unstructured":"Alvarez, G. et al. New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition. J. Enzyme Inhib. Med. Chem. 29, 198\u2013204 (2014).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"59460_CR35","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.bmc.2006.01.007","volume":"14","author":"A Gerpe","year":"2006","unstructured":"Gerpe, A. et al. Indazole N-oxide derivatives as antiprotozoal agents: Synthesis, biological evaluation and mechanism of action studies. Bioorganic Med. Chem. 14, 3467\u20133480 (2006).","journal-title":"Bioorganic Med. Chem."},{"issue":"3","key":"59460_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/ph11030067","volume":"11","author":"Natalia Sierra","year":"2018","unstructured":"Sierra, N. et al. Looking for novel capsid protein multimerization inhibitors of feline immunodeficiency virus. Pharmaceuticals 11 (2018).","journal-title":"Pharmaceuticals"},{"key":"59460_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3109\/14756366.2012.700928","volume":"5","author":"G Alvarez","year":"2013","unstructured":"Alvarez, G. et al. 1,2,4-thiadiazol-5(4H)-ones: a new class of selective inhibitors of Trypanosoma cruzi triosephosphate isomerase. Study of the mechanism of inhibition. J. Enzyme Inhib. Med. Chem. 5, 981\u2013989 (2013).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"59460_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"D66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. Sect. D. Biol. Crystallogr. D66, 125\u2013132 (2010).","journal-title":"Sect. D. Biol. Crystallogr."},{"key":"59460_CR39","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ Mccoy","year":"2007","unstructured":"Mccoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"59460_CR40","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1021\/bi500458t","volume":"53","author":"X Zhai","year":"2014","unstructured":"Zhai, X. et al. Enzyme Architecture: The Effect of Replacement and Deletion Mutations of Loop 6 on Catalysis by Triosephosphate Isomerase. Biochem. 53, 3486\u20133501 (2014).","journal-title":"Biochem."},{"key":"59460_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymeth.2011.07.005","volume":"55","author":"PD Adamsa","year":"2012","unstructured":"Adamsa, P. D. et al. The Phenix Software for Automated Determination of Macromolecular Structures. Methods 55, 94\u2013106 (2012).","journal-title":"Methods"},{"key":"59460_CR42","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"59460_CR43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"D67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP 4 suite and current developments. Acta Crystallogr. Sect. D. Biol. Crystallogr. D67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"59460_CR44","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/prot.10286","volume":"50","author":"SC Lovell","year":"2003","unstructured":"Lovell, S. C. et al. Structure Validation by C Geometry: and C Deviation. PROTEINS Struct. Funct. Genet. 50, 437\u2013450 (2003).","journal-title":"PROTEINS Struct. Funct. Genet."},{"key":"59460_CR45","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"key":"59460_CR46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"59460_CR47","doi-asserted-by":"publisher","first-page":"e0004834","DOI":"10.1371\/journal.pntd.0004834","volume":"10","author":"F Ferraro","year":"2016","unstructured":"Ferraro, F. et al. Identification of Chalcones as Fasciola hepatica Cathepsin L Inhibitors Using a Comprehensive Experimental and Computational Approach. PLoS Negl. Trop. Dis. 10, e0004834 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"59460_CR48","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.3390\/molecules24132348","volume":"24","author":"F Ferraro","year":"2019","unstructured":"Ferraro, F. et al. Cathepsin L Inhibitors with Activity against the Liver Fluke Identified from a Focus Library of Quinoxaline1,4-di-N-Oxide Derivatives. Molecules. 24, 2348 (2019).","journal-title":"Molecules."},{"key":"59460_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0014-4894(87)90077-4","volume":"63","author":"JL Bennett","year":"1987","unstructured":"Bennett, J. L. & Keehler, P. Fasciola hepatica: Action in vitro of triclabendazole on immature and adult stages. Exp. Parasitol. 63, 49\u201357 (1987).","journal-title":"Exp. Parasitol."},{"key":"59460_CR50","doi-asserted-by":"publisher","first-page":"e0005680","DOI":"10.1371\/journal.pntd.0005680","volume":"11","author":"T Long","year":"2017","unstructured":"Long, T. et al. Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target. PLoS Negl. Trop. Dis. 11, e0005680 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"59460_CR51","doi-asserted-by":"publisher","first-page":"e0004356","DOI":"10.1371\/journal.pntd.0004356","volume":"10","author":"T Long","year":"2016","unstructured":"Long, T. et al. Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni. Plos Negl. Trop. Dis. 10, e0004356 (2016).","journal-title":"Plos Negl. Trop. Dis."},{"key":"59460_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2307\/3280632","volume":"67","author":"PF Basch","year":"1981","unstructured":"Basch, P. F. Cultivation of Schistosoma mansoni In vitro. I. Establishment of Cultures from Cercariae and Development until Pairing. J. Parasitol. 67, 179\u2013185 (1981).","journal-title":"J. Parasitol."},{"key":"59460_CR53","doi-asserted-by":"crossref","unstructured":"Kyere-Davies, G. et al. Effect of Phenotypic Screening of Extracts and Fractions of Erythrophleum ivorense Leaf and Stem Bark on Immature and Adult Stages of Schistosoma mansoni. J. Parasitol. Res. ID 9431467 (2018).","DOI":"10.1155\/2018\/9431467"},{"key":"59460_CR54","unstructured":"OECD Guidelines for the Testing of Chemicals, Section 4, Test No. 425: Acute Oral Toxicity - Up-and-Down Procedure. Guidel. Test. Chem. 26 (2001)."},{"key":"59460_CR55","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4939-8630-9_8","volume":"1824","author":"G Alvarez","year":"2018","unstructured":"Alvarez, G. Bioguided Design of Trypanosomicidal Compounds: in Methods and Protocols. Methods Mol. Biol. 1824, 139\u2013163 (2018).","journal-title":"Methods Mol. Biol."},{"key":"59460_CR56","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1128\/AAC.03814-14","volume":"59","author":"G \u00c1lvarez","year":"2015","unstructured":"\u00c1lvarez, G. et al. Identification of a new amide-containing thiazole as a drug candidate for treatment of chagas\u2019 disease. Antimicrob. Agents Chemother. 59, 1398\u20131404 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"59460_CR57","first-page":"1","volume":"8","author":"P Carasi","year":"2017","unstructured":"Carasi, P. et al. Heme-oxygenase-1 expression contributes to the immunoregulation induced by Fasciola hepatica and promotes infection. Front. Immunol. 8, 1\u201315 (2017).","journal-title":"Front. Immunol."},{"key":"59460_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 1\u201313 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59460-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59460-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59460-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T15:27:47Z","timestamp":1722439667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59460-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59460"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59460-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]},"assertion":[{"value":"16 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2587"}}